Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report
Rhea-AI Summary
Progyny, Inc. (Nasdaq: PGNY), a leading fertility, family building, and women's health benefits solution provider, has announced its plans to report Q2 2024 financial results on August 6, 2024, after market close. The company will host a conference call at 4:45 P.M. ET (1:45 P.M. PT) to discuss the results.
Interested participants can join the call using specific dial-in numbers and passcode. A live webcast and archive of the call will be available on the company's investor relations website. Progyny is recognized for its innovative approach to fertility and women's health benefits, focusing on comprehensive solutions that benefit employers, patients, and physicians while optimizing clinical outcomes and reducing healthcare costs.
Positive
- Progyny is planning to report its Q2 2024 financial results, indicating ongoing business operations and transparency
- The company is hosting a conference call to discuss results, showing commitment to investor communication
- Progyny has been recognized as a TIME100 Most Influential Company and CNBC Disruptor 50, suggesting strong market position
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, PGNY gained 3.06%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 2024.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Tuesday, August 13, 2024 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When will Progyny (PGNY) report its Q2 2024 financial results?
What time is Progyny's (PGNY) Q2 2024 earnings conference call?
How can investors access Progyny's (PGNY) Q2 2024 earnings call?
What services does Progyny (PGNY) offer?
